Bar-Or, Amit et al "Interim Analysis of the OBOE (Ocrelizumab Biomarker Outcome Evaluation) Study in Multiple Sclerosis (MS) (S24.002)." Neurology 90.15 Supplement (2018): S24.002. Web. 16 Oct. 2019.